<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:department>Sch of Chemistry</gtr:department><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A082A48E-7286-45C7-BDA9-B04AF407E48E"><gtr:id>A082A48E-7286-45C7-BDA9-B04AF407E48E</gtr:id><gtr:firstName>Alison</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Ashcroft</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/FFFF81AC-E4EC-4839-8178-428C9F763EB0"><gtr:id>FFFF81AC-E4EC-4839-8178-428C9F763EB0</gtr:id><gtr:firstName>Andrew</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Wilson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FF039069%2F1"><gtr:id>FD892AFA-D36A-48F4-B9EC-0CD5CDF950B9</gtr:id><gtr:title>Metal Complexes as Inhibitors of Protein-Protein Interactions</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/F039069/1</gtr:grantReference><gtr:abstractText>Although many cellular processes depend upon enzymatic reactions, protein-protein interactions populate a significant number of regulatory pathways. Thus an explosion of interest in their study mirrors a pivotal role in diseased states. In order to manipulate biological systems effectively, there is a pressing need for small molecules that inhibit these interactions through strong and selective recognition of the interacting surfaces. The internal 'lock and key' type enzyme-substrate molecular recognition model has led to a good understanding of how to design small molecule inhibitors. However, it is not clear how the external 'hand gripping a ball' type recognition that occurs in protein-protein interactions, can be replicated using small molecules. Protein-protein interactions involve complementary large shapeless surfaces with multiple non-covalent contacts. In this work we will use small, easy to make, building-blocks that can be brought together using either a template directed synthesis, or self-organisation, to make 'protein surface mimics'; molecular entities that possess the molecular information necessary to recognise a protein surface and block the interaction it makes with its partner. Template- directed synthesis and self-assembly are methods used to assemble complex architectures from smaller components. They use the information within the components as an instruction set for the construction of the complex architecture. Methods that can do this are essential to the development of new strategies to understand and combat disease.</gtr:abstractText><gtr:fund><gtr:end>2011-09-07</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2008-09-08</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>331528</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The objective of this collaborative project (EP/F039069 and EP/F038712) with Queens University Belfast (QUB) was to demonstrate that functionalized metal tris(chelate) complexes can (a) be used as specific and selective receptors for protein-surfaces (b) be used to perturb protein-protein interactions. We were able to illustrate that functionalized ruthenium tris(chelate) complexes can act as potent and selective sensors for solvent exposed surfaces (Chem. Eur. J. 2010, 16, 100-103) and that the projection/ arrangement of protein binding groups from the ruthenium tris(chelate) complexes plays a significant role in determining the affinity of interaction with target proteins (Chem. Commun. 2011, 559-561 - collaborative publication with QUB). A thorough biophysical study on the molecular recognition properties of these ruthenium complexes has been undertaken, demonstrating they can be used to perturb protein-protein interactions (cyctochrome c- cytochrome c peroxidise), providing insights into the thermodynamic bases of protein-surface recognition and illustrating that the complexes perturb the stability of target proteins (Org. Biomol. Chem., 2013, 11, 2206-2212). These results illustrate that it is indeed possible to identify specific and selective receptors for protein-surfaces. In addition, we have illustrated that analogous iron tris(chelate) complexes which are labile can be used for protein surface recognition - in principle this is advantageous because several ligands in the presence of iron can form a virtual library inter-converting iron tris(chelate) complexes and upon addition of a template protein the library &amp;quot;natural selection&amp;quot; of the highest affinity receptor for the protein will take place. A detailed study on the speciation of such libraries using electrospray ionisation mass spectrometry (ESI-MS) has been performed (Chem. Eur. J., 2012, 18, 13733-13742). Finally, an additional collaborative opportunity with the Whitehouse group (Astbury Centre, Leeds) to study cellular uptake properties of these complexes presented itself during the course of the project and somewhat unexpectedly these compounds are efficiently taken-up into cells (Bioorg. Med. Chem. Lett., 2012, 22, 985-988), opening up new horizons for the development of these compounds as cell permeable inhibitors of protein-protein interactions. In summary, this project has been a significant success, resulting in a number of collaborative publications and demonstrating that metal tris(chelates) represent suitable scaffolds to develop a greater understanding of how to inhibit protein-protein interactions</gtr:description><gtr:firstYearOfImpact>2010</gtr:firstYearOfImpact><gtr:id>3185705D-7F0F-411B-BB40-DDB3F98ADF75</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:outcomeId>545231b5c09284.78769763</gtr:outcomeId><gtr:sector>Chemicals,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The objective of this collaborative project (EP/F039069 and EP/F038712) with Queens University Belfast (QUB) was to demonstrate that functionalized metal tris(chelate) complexes can (a) be used as specific and selective receptors for protein-surfaces (b) be used to perturb protein-protein interactions (PPIs). We were able to illustrate that functionalized ruthenium tris(chelate) complexes can act as potent and selective sensors for solvent exposed surfaces (Chem. Eur. J. 2010, 16, 100-103) and that the projection/ arrangement of protein binding groups from the ruthenium tris(chelate) complexes plays a significant role in determining the affinity of interaction with target proteins (Chem. Commun. 2011, 559-561 - collaborative publication with QUB). A thorough biophysical study on the molecular recognition properties of these ruthenium complexes has been undertaken, demonstrating they can be used to perturb protein-protein interactions (cyctochrome c- cytochrome c peroxidise), providing insights into the thermodynamic bases of protein-surface recognition and illustrating that the complexes perturb the stability of target proteins (Org. Biomol. Chem., 2013, 11, 2206-2212). These results illustrate that it is indeed possible to identify specific and selective receptors for protein-surfaces. In addition, we have illustrated that analogous iron tris(chelate) complexes which are labile can be used for protein surface recognition - in principle this is advantageous because several ligands in the presence of iron can form a virtual library inter-converting iron tris(chelate) complexes and upon addition of a template protein the library &amp;quot;natural selection&amp;quot; of the highest affinity receptor for the protein will take place. A detailed study on the speciation of such libraries using electrospray ionisation mass spectrometry (ESI-MS) has been performed (Chem. Eur. J., 2012, 18, 13733-13742). Finally, an additional collaborative opportunity with the Whitehouse group (Astbury Centre, Leeds) to study cellular uptake properties of these complexes presented itself during the course of the project and somewhat unexpectedly these compounds are efficiently taken-up into cells (Bioorg. Med. Chem. Lett., 2012, 22, 985-988), opening up new horizons for the development of these compounds as cell permeable inhibitors of protein-protein interactions. In summary, this project has been a significant success, resulting in a number of collaborative publications and demonstrating that metal tris(chelates) represent suitable scaffolds to develop a greater understanding of how to inhibit protein-protein interactions</gtr:description><gtr:exploitationPathways>Several research groups are now adopting our conceptual approach in the development of PPI inhibitors, whilst in our own work we could now apply the approach to therapeutically important PPIs</gtr:exploitationPathways><gtr:id>7A9F2DE9-4374-4055-9172-5327DCCF607D</gtr:id><gtr:outcomeId>r-2341149702.98591047781be80</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://www.chem.leeds.ac.uk/andrew-wilson/wilson-group.html</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>F8E34456-157D-421D-B878-CA6B1B513510</gtr:id><gtr:title>Metal complexes as &amp;quot;protein surface mimetics&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/271496d150e9fd39b1221db7a83ff5a7"><gtr:id>271496d150e9fd39b1221db7a83ff5a7</gtr:id><gtr:otherNames>Hewitt SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>5a787d1a50af11.75600130</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B99C6F90-AE0F-4CFA-AF6E-623E92202078</gtr:id><gtr:title>Protein destabilisation by ruthenium(II) tris-bipyridine based protein-surface mimetics.</gtr:title><gtr:parentPublicationTitle>Organic &amp; biomolecular chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/198c59f3d9164ce86699a45604a6c0c4"><gtr:id>198c59f3d9164ce86699a45604a6c0c4</gtr:id><gtr:otherNames>Wilson AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1477-0520</gtr:issn><gtr:outcomeId>doi_53d030030728c2ff</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07AD2D5B-F96B-4A16-BBD4-08D5C674A852</gtr:id><gtr:title>Protein surface recognition using geometrically pure Ru(II) tris(bipyridine) derivatives.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b7f72e1e3423670e226327418689a28"><gtr:id>6b7f72e1e3423670e226327418689a28</gtr:id><gtr:otherNames>Filby MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>doi_53d02c02cd6ee7a8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A91FD824-38EB-4DA9-9955-8BE563517DE5</gtr:id><gtr:title>Selective protein-surface sensing using ruthenium(II) tris(bipyridine) complexes.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/230e7dd22a86d46ca8c651ca315e0c03"><gtr:id>230e7dd22a86d46ca8c651ca315e0c03</gtr:id><gtr:otherNames>Muldoon J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>doi_53cfc2fc2cc01ded</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50670175-28D4-4B1C-AAF7-E0C23A2CD3A6</gtr:id><gtr:title>Protein sensing and discrimination using highly functionalised ruthenium(ii) tris(bipyridyl) protein surface mimetics in an array format.</gtr:title><gtr:parentPublicationTitle>Chemical communications (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/271496d150e9fd39b1221db7a83ff5a7"><gtr:id>271496d150e9fd39b1221db7a83ff5a7</gtr:id><gtr:otherNames>Hewitt SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1359-7345</gtr:issn><gtr:outcomeId>5a3519d1e34f28.13013043</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F78249A5-F238-49A9-847C-AEB7610D4A36</gtr:id><gtr:title>The use of electrospray mass spectrometry to determine speciation in a dynamic combinatorial library for anion recognition.</gtr:title><gtr:parentPublicationTitle>Chemistry (Weinheim an der Bergstrasse, Germany)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2f385764d6c062d45c3015473e7ca215"><gtr:id>2f385764d6c062d45c3015473e7ca215</gtr:id><gtr:otherNames>Phillips HI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0947-6539</gtr:issn><gtr:outcomeId>doi_53cfc3fc31a968ee</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29050AB8-AD26-466A-806E-26476CE99AE1</gtr:id><gtr:title>Inhibition of protein-protein interactions using designed molecules.</gtr:title><gtr:parentPublicationTitle>Chemical Society reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/198c59f3d9164ce86699a45604a6c0c4"><gtr:id>198c59f3d9164ce86699a45604a6c0c4</gtr:id><gtr:otherNames>Wilson AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0306-0012</gtr:issn><gtr:outcomeId>doi_53d02a02acf1693b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E91AC82D-35DC-4032-849B-B0B371537B4A</gtr:id><gtr:title>Cellular uptake of highly-functionalized ruthenium(II) tris-bipyridine protein-surface mimetics.</gtr:title><gtr:parentPublicationTitle>Bioorganic &amp; medicinal chemistry letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4507b220b9934401be7c3c66c090cbcf"><gtr:id>4507b220b9934401be7c3c66c090cbcf</gtr:id><gtr:otherNames>Turrell SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0960-894X</gtr:issn><gtr:outcomeId>doi_53cfe7fe7042e0ca</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>879E9B48-68D6-4C84-932A-99783BC36397</gtr:id><gtr:title>Protein Surface Mimetics: Understanding How Ruthenium Tris(Bipyridines) Interact with Proteins.</gtr:title><gtr:parentPublicationTitle>Chembiochem : a European journal of chemical biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/271496d150e9fd39b1221db7a83ff5a7"><gtr:id>271496d150e9fd39b1221db7a83ff5a7</gtr:id><gtr:otherNames>Hewitt SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1439-4227</gtr:issn><gtr:outcomeId>58a6c65fde2a52.19455238</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/F039069/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>0B9701E7-D17F-4963-82DA-B3926A65B50A</gtr:id><gtr:percentage>60</gtr:percentage><gtr:text>Biological &amp; Medicinal Chem.</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>454398F2-57A6-4959-8845-0F248CF4D5C4</gtr:id><gtr:percentage>15</gtr:percentage><gtr:text>Chemical Synthetic Methodology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>D59C2DC2-AD17-4980-92F3-677EB001B765</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>Combinatorial Chemistry</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>